{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T23:19:29Z","timestamp":1764890369496,"version":"3.46.0"},"reference-count":26,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ym0126121"],"award-info":[{"award-number":["JP25ym0126121"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,10,1]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This research paper presents a study protocol for an exploratory clinical trial evaluating the safety and potential efficacy of autologous peripheral blood mononuclear cell (PBMNC)-loaded injectable cell scaffold (ICS-001) for angiogenic therapy in chronic limb-threatening ischaemia (CLTI). CLTI, the advanced stage of peripheral artery disease, presents significant therapeutic challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      Angiogenic therapy using ICS-001 with PBMNCs\u2014a novel approach designed to enhance local cell retention and promote neovascularisation\u2014will be explored. The study will address the pathophysiology of CLTI, the limitations of current treatments and the rationale for cell-based therapies, alongside the clinical trial design for evaluating the safety and efficacy of ICS-001. We hypothesise that ICS-001 will improve ulcer healing and reduce ischaemic rest pain in patients with CLTI. This paper outlines the methodology, including patient selection, CD34\n                      <jats:sup>+<\/jats:sup>\n                      cell mobilisation, scaffold preparation, injection protocols, clinical assessments, data collection and safety monitoring. The anticipated results, discussion and conclusion will offer insight into the clinical significance and potential impact of ICS-001 as a pioneering angiogenic therapy for CLTI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The institutional review boards of all participating hospitals approved this study protocol (latest version V.6.0, 5 June 2025). Final data will be made publicly available. A report detailing the study results will be submitted for publication in an appropriate peer-reviewed journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data availability statement<\/jats:title>\n                    <jats:p>\n                      Data are available on reasonable request. Technical appendix, statistical code is available by contacting the corresponding author. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) licence, which permits others to distribute, remix, adapt, build on this work non-commercially, and licence their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated and the use is non-commercial. See:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/\">http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>jRCT2052230115, Japan Registry of Clinical Trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-107486","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T08:56:05Z","timestamp":1761209765000},"page":"e107486","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Autologous peripheral blood mononuclear cell-loaded injectable cell scaffold (ICS-001) for revolutionising angiogenic therapy: a study protocol for an exploratory clinical trial"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3513-7712","authenticated-orcid":false,"given":"Kenichi","family":"Yamahara","sequence":"first","affiliation":[{"name":"Laboratory of Molecular and Cellular Therapy, Institute for Advanced Medical Sciences, Hyogo Medical University, Nishinomiya, Hyogo Prefecture, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokuni","family":"Akahori","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Renal Medicine, Hyogo Medical University, Nishinomiya, Hyogo Prefecture, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Hyogo Medical University, Nishinomiya, Hyogo Prefecture, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Suna","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Renal Medicine, Hyogo Medical University, Nishinomiya, Hyogo Prefecture, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yoshihara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Hyogo Prefecture, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Renal Medicine, Hyogo Medical University, Nishinomiya, Hyogo Prefecture, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Kakibuchi","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Hyogo Medical University, Nishinomiya, Hyogo Prefecture, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Oita Oka Hospital, Oita, Oita Prefecture, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumichi","family":"Kogai","sequence":"additional","affiliation":[{"name":"BioX Inc, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Sato","sequence":"additional","affiliation":[{"name":"Gunze Medical Limited, Osaka, Osaka Prefecture, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Department of Premier Preventive Medicine, Osaka Metropolitan University, Osaka, Osaka Prefecture, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Furuzono","sequence":"additional","affiliation":[{"name":"Department of Biological System Engineering, Graduate School of Biology-Oriented Science and Technology, Kindai University, Kinokawa, Wakayama Prefecture, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Tani-Yokoyama","sequence":"additional","affiliation":[{"name":"Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo Prefecture, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo Prefecture, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Fujita","sequence":"additional","affiliation":[{"name":"Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo Prefecture, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko","family":"Kawamoto","sequence":"additional","affiliation":[{"name":"Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo Prefecture, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"2025120415082933000_15.10.e107486.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2013.08.003"},{"key":"2025120415082933000_15.10.e107486.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2019.02.016"},{"key":"2025120415082933000_15.10.e107486.3","doi-asserted-by":"crossref","unstructured":"Iida O , Takahara M , Soga Y , et al . Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia. Circ: Cardiovascular Interventions 2017;10. doi:10.1161\/CIRCINTERVENTIONS.117.005531","DOI":"10.1161\/CIRCINTERVENTIONS.117.005531"},{"key":"2025120415082933000_15.10.e107486.4","first-page":"466","article-title":"Therapeutic angiogenesis in critical limb ischemia","volume":"64","author":"Ouma","year":"2013","journal-title":"Angiol Open Access"},{"key":"2025120415082933000_15.10.e107486.5","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/127170","article-title":"Angiogenesis and its therapeutic opportunities","volume":"2013","author":"Yoo","year":"2013","journal-title":"Mediators Inflamm"},{"key":"2025120415082933000_15.10.e107486.6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1515\/jce-2017-0028","article-title":"Therapeutic Angiogenesis for Severely Ischemic Limbs \u2014 from Bench to Bedside in Acute Vascular Care","volume":"3","author":"Benedek","year":"2017","journal-title":"J Cardiovascul Emerg"},{"key":"2025120415082933000_15.10.e107486.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.06.025"},{"key":"2025120415082933000_15.10.e107486.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.07.031"},{"key":"2025120415082933000_15.10.e107486.9","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-13-0864"},{"key":"2025120415082933000_15.10.e107486.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2009.07.050"},{"key":"2025120415082933000_15.10.e107486.11","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1253\/circj.CJ-17-1220","article-title":"Outcome From a Randomized Controlled Clinical Trial\u3000- Improvement of Peripheral Arterial Disease by Granulocyte Colony-Stimulating Factor-Mobilized Autologous Peripheral-Blood-Mononuclear Cell Transplantation (IMPACT)","volume":"82","author":"Horie","year":"2018","journal-title":"Circ J"},{"key":"2025120415082933000_15.10.e107486.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035199","article-title":"Enhancement of cell-based therapeutic angiogenesis using a novel type of injectable scaffolds of hydroxyapatite-polymer nanocomposite microspheres","volume":"7","author":"Mima","year":"2012","journal-title":"PLoS One"},{"key":"2025120415082933000_15.10.e107486.13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3400\/avd.ra.20-00002","article-title":"Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-derived Mononuclear Cell Implantation in Patients with No-option Critical Limb Ischemia","volume":"13","author":"Yanishi","year":"2020","journal-title":"Ann Vasc Dis"},{"key":"2025120415082933000_15.10.e107486.14","first-page":"26","article-title":"Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia","volume":"4","author":"Walter","year":"2011","journal-title":"Circ: Cardiovascular Interventions"},{"key":"2025120415082933000_15.10.e107486.15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.012913"},{"key":"2025120415082933000_15.10.e107486.16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbrc.2014.10.045","article-title":"Injectable cell scaffold restores impaired cell-based therapeutic angiogenesis in diabetic mice with hindlimb ischemia","volume":"454","author":"Takeda","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"2025120415082933000_15.10.e107486.17","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2015.00336","article-title":"Mitochondrial Regulation of the Muscle Microenvironment in Critical Limb Ischemia","volume":"6","author":"Ryan","year":"2015","journal-title":"Front Physiol"},{"key":"2025120415082933000_15.10.e107486.18","doi-asserted-by":"crossref","unstructured":"MacLauchlan S , Yu J , Parrish M , et al . Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2. Proc Natl Acad Sci USA 2011;108. doi:10.1073\/pnas.1104357108","DOI":"10.1073\/pnas.1104357108"},{"key":"2025120415082933000_15.10.e107486.19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/sctm.20-0132","article-title":"Coadministration of endothelial and smooth muscle cells derived from human induced pluripotent stem cells as a therapy for critical limb ischemia","volume":"10","author":"Park","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"2025120415082933000_15.10.e107486.20","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvw220"},{"key":"2025120415082933000_15.10.e107486.21","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.110"},{"key":"2025120415082933000_15.10.e107486.22","doi-asserted-by":"publisher","DOI":"10.1177\/1753944708097728"},{"key":"2025120415082933000_15.10.e107486.23","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1253\/circj.CJ-19-0240","article-title":"Autologous CD34+ Cell Therapy for Ischemic Tissue Repair","volume":"83","author":"Sietsema","year":"2019","journal-title":"Circ J"},{"key":"2025120415082933000_15.10.e107486.24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addr.2017.09.001","article-title":"Stem cell-based peripheral vascular regeneration","volume":"120","author":"Fujita","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"2025120415082933000_15.10.e107486.25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1411295111"},{"key":"2025120415082933000_15.10.e107486.26","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.clinthera.2018.05.008","article-title":"Establishment of the National Consortium for Regenerative Medicine and National Regenerative Medicine Database in Japan","volume":"40","author":"Okada","year":"2018","journal-title":"Clin Ther"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-107486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T23:15:03Z","timestamp":1764890103000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-107486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,23]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/bmjopen-2025-107486"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-107486","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}